[{"id":"eff23d5a-07ca-4bd0-b111-e2ee2ef96220","acronym":"","url":"https://clinicaltrials.gov/study/NCT05842707","created_at":"2023-05-06T15:04:02.816Z","updated_at":"2024-07-02T16:35:48.974Z","phase":"Phase 1/2","brief_title":"Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma","source_id_and_acronym":"NCT05842707","lead_sponsor":"Aibin Liang，MD，Ph.D.","biomarkers":" CD70","pipe":"","alterations":" ","tags":["CD70"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e dualCAR-NK19/70"],"overall_status":"Recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 01/18/2023","start_date":" 01/18/2023","primary_txt":" Primary completion: 01/18/2028","primary_completion_date":" 01/18/2028","study_txt":" Completion: 01/18/2029","study_completion_date":" 01/18/2029","last_update_posted":"2023-05-04"},{"id":"72825679-0a90-44dd-8f03-cc33bf0d6f85","acronym":"","url":"https://clinicaltrials.gov/study/NCT05667155","created_at":"2022-12-28T16:01:39.436Z","updated_at":"2024-07-02T16:35:56.379Z","phase":"Phase 1","brief_title":"Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma","source_id_and_acronym":"NCT05667155","lead_sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","biomarkers":" CD20 • CD19","pipe":" | ","alterations":" CD19 expression • CD20 negative","tags":["CD20 • CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression • CD20 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e dualCAR-NK19/70"],"overall_status":"Recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 12/15/2022","start_date":" 12/15/2022","primary_txt":" Primary completion: 01/01/2025","primary_completion_date":" 01/01/2025","study_txt":" Completion: 12/30/2025","study_completion_date":" 12/30/2025","last_update_posted":"2023-02-06"}]